» Authors » Emanuela Carlotti

Emanuela Carlotti

Explore the profile of Emanuela Carlotti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 696
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Carlotti E, Wrench D, Rosignoli G, Marzec J, Sangaralingam A, Hazanov L, et al.
PLoS One . 2015 Sep; 10(9):e0134833. PMID: 26325507
Understanding the dynamics of evolution of Follicular Lymphoma (FL) clones during disease progression is important for monitoring and targeting this tumor effectively. Genetic profiling of serial FL biopsies and examples...
12.
Okosun J, Bodor C, Wang J, Araf S, Yang C, Pan C, et al.
Nat Genet . 2013 Dec; 46(2):176-181. PMID: 24362818
Follicular lymphoma is an incurable malignancy, with transformation to an aggressive subtype representing a critical event during disease progression. Here we performed whole-genome or whole-exome sequencing on 10 follicular lymphoma-transformed...
13.
Wrench D, Leighton P, Skibola C, Conde L, Cazier J, Matthews J, et al.
Blood . 2011 Jan; 117(11):3147-50. PMID: 21233317
Inherited risk determinants for follicular lymphoma (FL) have recently been described in the immune gene-rich human leukocyte antigen region on chromosome 6p. The known importance of host immune response to...
14.
Carlotti E, Gribben J
Blood . 2009 Oct; 114(15):3133-4. PMID: 19815676
In this issue of Blood, Gentles and colleagues used a computational model to investigate FL and transformed DLBCL, and identified the acquisition of an ESC-like signature as a key feature...
15.
Carlotti E, Wrench D, Matthews J, Iqbal S, Davies A, Norton A, et al.
Blood . 2009 Feb; 113(15):3553-7. PMID: 19202129
To investigate the cell of origin linking follicular (FL) and transformed (t-FL) lymphomas, we analyzed the somatic hypermutation (SHM) pattern of the variable region of the immunoglobulin heavy gene (IgH-VH)...
16.
Wrench D, Waters R, Carlotti E, Iqbal S, Matthews J, Calaminici M, et al.
Haematologica . 2008 Nov; 94(1):148-50. PMID: 19029147
No abstract available.
17.
OShea D, ORiain C, Taylor C, Waters R, Carlotti E, MacDougall F, et al.
Blood . 2008 Jul; 112(8):3126-9. PMID: 18628487
The International Prognostic Index and the Follicular Lymphoma International Prognostic Index are widely used for the risk assessment of follicular lymphoma (FL). Although molecular studies have provided insight into the...
18.
Carlotti E, Palumbo G, Oldani E, Tibullo D, Salmoiraghi S, Rossi A, et al.
Haematologica . 2007 Jul; 92(8):1127-30. PMID: 17650444
We analyzed FcgammaRIIIA-158V/F and FcgammaRIIA-131H/R polymorphisms in a cohort of 94 newly diagnosed follicular lymphoma (FL) patients sequentially treated with CHOP and Rituximab. With a median follow-up of 5.8 years,...
19.
Pulsoni A, Della Starza I, Frattarelli N, Ghia E, Carlotti E, Cavalieri E, et al.
Br J Haematol . 2007 Apr; 137(3):216-20. PMID: 17408460
Stage I/IIA follicular lymphoma (FL) is considered a localised disease that can be adequately treated with radiotherapy alone. Bone marrow (BM) and peripheral blood (PB) involvement in FL was investigated...
20.
Rambaldi A, Carlotti E, Oldani E, Della Starza I, Baccarani M, Cortelazzo S, et al.
Blood . 2005 Jan; 105(9):3428-33. PMID: 15637137
By real-time quantitative polymerase chain reaction (RQ-PCR), we evaluated BCL2/IgH(+) cells in the bone marrow (BM) and peripheral blood (PB) from 86 patients with follicular lymphoma treated with the sequential...